EP300 and breast carcinoma: Loss of EP300 heterozygosity has been described in breast carcinomas [9], somatic EP300 mutations have been identified in several malignancies [10] and EP300-deficient colon carcinoma cells show phenotypic changes characteristic of EMT [11].